Invention Application
- Patent Title: NOVEL SPECIFIC HCV NS3 PROTEASE INHIBITORS
- Patent Title (中): 新型特异性HCV NS3蛋白酶抑制剂
-
Application No.: US13284641Application Date: 2011-10-28
-
Publication No.: US20120129765A1Publication Date: 2012-05-24
- Inventor: Jerome Courcambeck , Philippe Halfon , Mourad Bouzidi , Steven J. Coats , Richard Anthony Whitaker
- Applicant: Jerome Courcambeck , Philippe Halfon , Mourad Bouzidi , Steven J. Coats , Richard Anthony Whitaker
- Applicant Address: FR Marseille US GA Tucker
- Assignee: GENOSCIENCE,RFS Pharma, LLC
- Current Assignee: GENOSCIENCE,RFS Pharma, LLC
- Current Assignee Address: FR Marseille US GA Tucker
- Main IPC: A61K38/06
- IPC: A61K38/06 ; C07K5/083 ; A61P31/14
Abstract:
The present invention is directed to compounds, compositions and methods for treating or preventing viral infections, in particular, HCV in human patients or other animal hosts.
Public/Granted literature
- US08729014B2 Specific HCV NS3 protease inhibitors Public/Granted day:2014-05-20
Information query
IPC分类:
